Multi-country study on the prevalence and clinical features of peripheral arterial disease in asian type 2 diabetes patients at high risk of atherosclerosis

The Role of Triglyceride in Cardiovascular Disease in Asian Patients with Type 2 Diabetes - A Systematic Review

“…Among them, 14 studies were considered relevant to the topic. We further excluded 4 papers due to the lack of multivariate analysis [20][21][22][23]. As a result, a total of ten papers were included in the analysis, and the numbers of papers per country are shown in Table 1 (three from Hong Kong, two from Japan, two from Taiwan, one from South India, one from Indonesia, and one…”

“…However, the role of hypertriglyceridemia in the development of PAD remains controversial. In some case-control studies conducted in Asian, there were significant differences in the serum TG levels between disease and control groups [21,22], although in another study conducted in Taiwanese diabetic patients, TG was not a significant risk factor for PAD, assessed by both univariate and multivariate analysis [43]. As a result, hypertriglyceridemia may not be a significant risk factor for PAD.…”

Third Asian PAD Workshop

“…1) Statistics show that approximately 18% of diabetes patients have PAD. 2) The number of patients with diabetes is increasing with around 22 million Japanese (~17% of the Japanese population) now estimated to have diabetes or be at risk of diabetes. Similarly, the number of Chinese diabetes patients is estimated to be 92.4 million, 3) (7% of its population).…”

“…2) The mortality and cardiovascular event risks in PAD patients from KPSA were analysed. Cause of death was compared between PAD and non-PAD subjects.…”

“…Decades of progress in classification and consensus and cooperation between medical and surgical vascular, cardiovascular, vascular radiology and cardiology societies across the world has been undertaken to address this issue, as follows: TASC II was published in 2007 with goals to focus on key aspects of diagnosis and management, and to update the information based on new publications and the newer guidelines. 1,2) …”